Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphoma

13 Nov 2018

Abstract excerpt

// Shariful Islam 1 , Andrew L. Paek 2 , Michael Hammer 3 , Savithri Rangarajan 4 , Robert Ruijtenbeek 4 , Laurence Cooke 5 , Eric Weterings 6 and Daruka Mahadevan 5 1 Cancer Biology GIDP, University of Arizona Cancer Center, Tucson, AZ, USA 2 Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, USA 3 Division of Biotechnology, University of Arizona Cancer Center, Tucson, AZ, USA 4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30542505
DOI: 10.18632/oncotarget.26251

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-induced aneuploidy and polyploidy is a mechanism of disease relapse in MYC/BCL2-addicted diffuse large B-cell lymphomaPMID 30542505Read ↗

Polyploidy in Cancer: Causal Mechanisms, Cancer-Specific Consequences, and Emerging TreatmentsSemantic proximity Read ↗

Drug therapy for double-hit lymphomaSemantic proximity Read ↗

Double-hit lymphomas: current paradigms and novel treatment approaches.Semantic proximity Read ↗

Therapeutic implication of concomitant chromosomal aberrations in patients with aggressive B-cell lymphomas.Semantic proximity Read ↗

Double hit lymphoma: from biology to therapeutic implications.Semantic proximity Read ↗

Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphomaSemantic proximity Read ↗

WEE1 kinase inhibition triggers severe chromosome pulverization in aneuploid cellsSemantic proximity Read ↗

Amitotic Cell Division, Malignancy, and Resistance to Anticancer Agents: A Tribute to Drs. Walen and RajaramanSemantic proximity Read ↗

RNA-sequencing dissects the transcriptome of polyploid cancer cells that are resistant to combined treatments of cisplatin with paclitaxel and docetaxelSemantic proximity Read ↗

Disentangling the roles of aneuploidy, chromosomal instability and tumour heterogeneity in developing resistance to cancer therapiesSemantic proximity Read ↗

Near-Haploidy and Low-Hypodiploidy in B-Cell Acute Lymphoblastic Leukemia: When Less Is Too MuchSemantic proximity Read ↗

Whole-Genome Doubling as a source of cancer: how, when, where, and why?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.